0113 2727560

Contact Us

Contact CPWY

Twitter Latest Tweets

Latest PSNC News

MHRA Drug Safety Update February 2019

Date issued 18th February 2019 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 7¬† February 2019:1) has been published and includes articles on: Carbimazole: Increased risk of congenital malformations; strengthened advice on contraception. Carbimazole: risk of acute pancreatitis. SGLT2 inhibitiors: reports of Fournier’s gangrene (necrotising fasciitis of the...

15 hours ago

Class 4 MHRA Drug Alert – Atropine Sulfate 3mg/10ml Solution for injection in pre-filled syringe (Laboratoire Aguettant)

Drug Alert No: EL (19) A/05 Date Issued: 18th February 2019 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for certain batches of Atropine Sulfate 3mg/10ml Solution for Injection in pre-filled syringe (Laboratoire Aguettant) Atropine Sulfate 3mg/10ml Solution for injection in pre-filled syringe. (Laboratoire Aguettant) PL 14434/0016 Batch Number...

17 hours ago

PSNC agrees strategic plan for 2019/20 at latest meeting

The PSNC Committee held the first of its new-style quarterly meetings this month, and agreed its plan for 2019/20. The Committee held important discussions on the NHS Long Term Plan, Brexit contingency planning, price concessions, service updates, and of course the commitment to Primary Care Networks (PCNs) made in the GP funding deal. The Committee...

17 hours ago

EPS Nominations

It is important if contractors are starting to collect nominations that they are aware of:

  • No inducements can be offered for patients to nominate your pharmacy for EPS R2. This means that money, gifts, points and discounts (along with anything else that may be classed as an inducement) must not be offered or given. The LPC is aware that some contractors do currently offer inducements for signing up to Prescription Collection Services. This must not happen for EPS R2 nominations.
  • Pharmacies must have ‘local accountable auditable processes' for obtaining explicit consent. Consent cannot be assumed to have been given just because a patient is signed up to your PCS service (even if your PCS leaflets make reference to EPS). As part of this consent process there is a range of information that must be given to the patient. Connecting for Health has produced a leaflet called "Explaining the Electronic Prescription Service - Information for patients and carers in England which can be downloaded here. These leaflets can be ordered from the Department of Health's Publication Orderline by clicking here or contacting 0300 123 1002.
  • Community Pharmacy West Yorkshire has produced an EPS Nomination Form to enable you to capture consent for nomination.
  • You may find it useful to have an SOP to cover your nomination processes. Both the NPA and Numark have developed template SOPs.
  • You will not currently be notified if a patient changes their nomination. It is the most recent nomination that counts.
  • Nominations can only be made on an EPS Release 2 system and by an individual with an EPS R2 smartcard. NHS England will be able to track all nominations and will use this data to investigate any issues. You must not share your smartcard with anybody else.
  • You must be aware of the NHS England 'Nomination: what you need to know' document which can be downloaded by clicking here.